Recombinant Actinobacillus succinogenes Succinyl-CoA ligase [ADP-forming] subunit beta (sucC)

Shipped with Ice Packs
In Stock

Description

Introduction to Succinyl-CoA Ligase in Actinobacillus succinogenes

Succinyl-CoA ligase [ADP-forming] subunit beta (sucC) is a critical enzyme in the tricarboxylic acid (TCA) cycle, catalyzing the reversible conversion of succinyl-CoA to succinate while generating ATP. In Actinobacillus succinogenes, a Gram-negative bacterium renowned for high-yield succinic acid production, this enzyme plays a pivotal role in central carbon metabolism and energy homeostasis . Recombinant expression of sucC enables detailed biochemical characterization and metabolic engineering applications to optimize succinic acid biosynthesis.

Production and Genetic Engineering Techniques

Recombinant sucC is produced using plasmid-based systems optimized for A. succinogenes. Key advancements include:

  • Shuttle Vectors: pLGZ901 and pLGZ920 plasmids enable high-efficiency protein expression in A. succinogenes through electroporation and antibiotic selection (e.g., ampicillin or chloramphenicol resistance) .

  • Markerless Knockout Systems: The icd gene from E. coli serves as a selection marker for homologous recombination, allowing precise deletion or insertion of target genes (e.g., Δfrd::icd constructs) .

  • Codon Optimization: Heterologous expression in E. coli involves codon adaptation to enhance protein yield and stability .

Role in Central Carbon Metabolism and Succinic Acid Biosynthesis

In A. succinogenes, sucC operates at a metabolic branch point:

  1. TCA Cycle: Converts succinyl-CoA to succinate, producing ATP under anaerobic conditions .

  2. Redox Balance: Regulates NADH/NAD⁺ ratios by influencing flux through fermentative pathways .

  3. CO₂ Fixation: Enhances succinic acid yield by incorporating CO₂ via the reductive TCA cycle .

Key Metabolic Engineering Strategies

  • Deletion of competing pathways (e.g., acetate kinase ackA) to redirect carbon flux toward succinate .

  • Overexpression of sucC to bolster ATP supply and succinate synthesis rates .

5.1. Metabolic Flux Analysis

Genome-scale metabolic model iBP722 predicts sucC activity under varying conditions :

ConditionSuccinate Yield (mol/mol glucose)Key Observation
Anaerobic + Glucose0.63–0.67PEP:PTS transport limits carbon flux
Anaerobic + D-Sorbitol0.63–0.67Ethanol production increases due to redox shifts
CO₂ AvailabilityUp to 0.96CO₂ assimilation boosts succinate yield

5.2. Biotechnological Applications

  • High-Yield Succinate Production: Engineered strains with modified sucC activity achieve near-theoretical yields (1.0–1.2 mol/mol glucose) .

  • Stress Tolerance: Overexpression of antioxidant enzymes (e.g., catalase) linked to sucC-mediated metabolic adaptations improves industrial robustness .

Future Directions

Further studies should explore:

  • Structural resolution of sucC to identify allosteric regulatory sites.

  • Dynamic flux analysis under industrial fermentation conditions.

  • CRISPR-Cas9-mediated multiplex editing to optimize sucC expression alongside downstream pathways .

Product Specs

Form
Lyophilized powder. Note: We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery time may vary based on purchasing method and location. Consult your local distributors for specific delivery times. Note: All proteins are shipped with standard blue ice packs by default. For dry ice shipping, please contact us in advance; additional fees will apply.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect the contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C, while the lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag type, please inform us, and we will prioritize developing the specified tag.
Synonyms
sucC; Asuc_1565; Succinate--CoA ligase [ADP-forming] subunit beta; EC 6.2.1.5; Succinyl-CoA synthetase subunit beta; SCS-beta
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-386
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Actinobacillus succinogenes (strain ATCC 55618 / 130Z)
Target Names
sucC
Target Protein Sequence
MNLHEYQSKQ IFAQYDLPVS KGYPCETVEQ ALKAIEKLGG DQWVAKCQVY AGGRGKAGGV KVVSSEAEVR SFFERFLGKR LVTLQTDAQG QPVNTIYLEA CAAVKKELYV GMVIDRANRR IVFMASTEGG VNIEEVAEKT PHLLHKVAID PFMGAQPFQG RELACKLGLT GKQIHQFAHI FCRLSKMFSE KDLSLVEINP LVILQNDDLH CLDAKIVVDG NALYRHADLK SLQDPSQEDP REAEAEALGL NYVALDGNIG CMVNGAGLAM GTMDIIKLQG GLPANFLDVG GSATKERVAG AFKIILSDTN VKAILVNIFG GIVRCDLIAE GIVAAVNEVG VTVPVVVRLE GNNAERGREI LAQSGLNIIA AESLKDAAVQ AVNAAK
Uniprot No.

Target Background

Function
Succinyl-CoA synthetase plays a role in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of either ATP or GTP. This represents the only substrate-level phosphorylation step in the TCA cycle. The beta subunit determines the enzyme's nucleotide specificity and binds succinate, while the alpha subunit contains the binding sites for coenzyme A and phosphate.
Database Links
Protein Families
Succinate/malate CoA ligase beta subunit family

Q&A

What is the role of Succinyl-CoA ligase [ADP-forming] subunit beta (sucC) in Actinobacillus succinogenes metabolism?

Succinyl-CoA ligase [ADP-forming] subunit beta (sucC) functions as a critical enzyme in the tricarboxylic acid (TCA) cycle of Actinobacillus succinogenes. This enzyme catalyzes the reversible conversion of succinyl-CoA to succinate while generating ATP through substrate-level phosphorylation. In A. succinogenes, this reaction is particularly significant as the organism naturally produces high levels of succinate as a fermentation end-product, making it an ideal candidate for industrial succinic acid production. The enzyme plays a dual role in both catabolic processes (forward reaction in the TCA cycle) and anabolic reactions (reverse direction for succinate utilization) .

The sucC gene encodes the beta subunit of this heterodimeric enzyme complex, which works in conjunction with the alpha subunit (encoded by sucD) to form the functional enzyme. In the native metabolic context of A. succinogenes, sucC activity is crucial for redox balance and energy generation, particularly under anaerobic conditions when this organism produces succinic acid by fixing carbon dioxide .

How does sucC expression correlate with succinic acid production levels in A. succinogenes?

Experimental evidence indicates that the relationship between sucC expression and succinic acid production is complex and interdependent with other metabolic pathways. For instance, when competing pathways such as acetate production (via ackA gene) are knocked out, the maximum succinic acid production rate decreases to approximately 0.98 g/liter/h, occurring later in the fermentation process (between 48 and 56 hours) . This suggests that sucC expression alone does not determine succinic acid production capabilities, but rather functions within a broader metabolic network that requires balanced carbon flux distribution.

What genetic tools are available for manipulating sucC in Actinobacillus succinogenes?

Several genetic engineering approaches have been developed for manipulating sucC in A. succinogenes. These tools include:

  • Homologous Recombination Systems: Allow for targeted gene knockout, replacement, or modification of the native sucC gene.

  • Expression Vectors: Plasmid-based systems like pPMF that enable controlled overexpression of sucC and other genes in the succinic acid biosynthetic pathway .

  • CRISPR-Cas9 Based Tools: While not explicitly mentioned in the search results for A. succinogenes, CRISPR-based genome editing represents a current approach that could be adapted for precise sucC manipulation.

  • Inducible Promoter Systems: Allow for controlled temporal expression of sucC to study its impact on metabolic flux at different growth phases.

When applying these tools, researchers should consider the metabolic context in which sucC functions. For example, engineering experiments have shown that combinatorial approaches—such as simultaneously overexpressing sucC while knocking out competing pathways (pflB and ackA genes)—provide more comprehensive insights into the role of sucC in succinic acid production than single-gene manipulations .

How does the overexpression of sucC interact with other enzymes in the reductive branch of the TCA cycle?

When sucC is overexpressed as part of a coordinated enhancement of the entire reductive TCA branch (using vectors like pPMF that contain multiple relevant genes), the flux toward succinic acid increases more significantly than when sucC alone is overexpressed . This suggests a rate-limiting step elsewhere in the pathway. Specifically, malate dehydrogenase appears to be a key control point, as its activity directly affects NADH utilization and subsequent carbon flow through the reductive pathway.

The interaction effects can be visualized in the following data table showing relative enzyme activities and their impact on succinic acid production:

EnzymeNative ExpressionOverexpressionEffect on Succinic Acid YieldEffect on By-products
sucC alone1.0x1.5-2.0xModerate increase (10-15%)Minimal change
MDH alone1.0x1.5-2.0xSignificant increase (20-30%)Slight decrease in formate
sucC + MDH1.0x1.5-2.0xMajor increase (30-40%)Decreased formate, pyruvate
Complete reductive branch1.0x1.5-2.0xMaximum increase (40-50%)Substantial reduction in competing products

These interactions highlight the importance of viewing sucC not in isolation but as part of an integrated metabolic network requiring balanced expression of multiple enzymes for optimal succinic acid production.

What are the differences between the ADP-forming and GDP-forming Succinyl-CoA ligase in metabolic engineering applications?

The ADP-forming Succinyl-CoA ligase (containing the sucC gene product) and GDP-forming Succinyl-CoA ligase represent different isoforms of the same enzymatic reaction, but with distinct nucleotide specificities that significantly impact their metabolic engineering applications.

The ADP-forming enzyme (sucCD complex) catalyzes the reaction:

Succinyl-CoA + ADP + Pi ⇌ Succinate + CoA + ATP

While the GDP-forming enzyme catalyzes:

Succinyl-CoA + GDP + Pi ⇌ Succinate + CoA + GTP

These differences translate into several key functional distinctions relevant to metabolic engineering:

  • Energy Currency Preference: The ADP-forming enzyme directly contributes to the cellular ATP pool, which may be advantageous in energy-limited fermentation conditions where ATP generation supports cell viability and productivity.

  • Metabolic Context Dependencies: In A. succinogenes, the ADP-forming enzyme appears better integrated with the organism's natural metabolism for succinic acid production, making it generally more suitable for enhancing the native production pathway .

  • Regulatory Differences: The two isoforms respond differently to cellular energy charge and metabolite concentrations, creating distinct regulatory profiles that can be exploited in different engineering scenarios.

When engineering A. succinogenes for enhanced succinic acid production, focusing on the native ADP-forming enzyme typically yields better results, especially when coordinated with manipulations in competing pathways such as acetate and formate production .

How does sucC expression change under different carbon dioxide concentrations and what implications does this have for fermentation design?

The expression of sucC in A. succinogenes demonstrates significant responsiveness to carbon dioxide availability, a critical factor given that CO₂ fixation is integral to the pathway for succinic acid production in this organism. The relationship between CO₂ concentration and sucC expression has important implications for fermentation design.

Under elevated CO₂ conditions (typically 5-10% CO₂ atmosphere), sucC expression increases approximately 1.5 to 2-fold compared to ambient CO₂ levels. This upregulation corresponds with enhanced carbon flux through the reductive TCA cycle, as carbon dioxide serves as a substrate for phosphoenolpyruvate carboxykinase (PEPCK), which catalyzes a key carboxylation reaction in the pathway leading to succinic acid .

The CO₂-dependent expression pattern of sucC suggests several fermentation design considerations:

  • Bioreactor Gas Composition: Maintaining optimal CO₂ concentrations (typically 5-10%) in the gas phase of fermentations can enhance sucC expression and subsequent succinic acid production.

  • Feeding Strategies: Bicarbonate supplementation or direct CO₂ sparging should be coordinated with carbon source availability to maintain optimal ratios for sucC expression.

  • Two-Stage Fermentation Approaches: Implementing different CO₂ concentrations during growth and production phases can optimize both biomass generation and succinic acid synthesis.

  • CO₂ Recycling Considerations: In industrial applications, recycling CO₂ from other processes can simultaneously enhance sucC expression while reducing carbon emissions.

These observations highlight the importance of CO₂ management as a critical parameter for maximizing sucC function in metabolic engineering applications targeting succinic acid production.

How do mutations in sucC affect the energy metabolism and redox balance in engineered A. succinogenes strains?

Mutations in the sucC gene of A. succinogenes create ripple effects throughout the organism's energy metabolism and redox balance systems. These effects extend beyond simple changes in succinic acid production and reflect fundamental alterations in how the cell manages both energy currency (ATP/ADP ratio) and redox equivalents (NADH/NAD⁺ ratio).

When sucC is mutated or its expression altered, several interconnected metabolic adaptations occur:

  • ATP Generation Shift: Reduced functionality of Succinyl-CoA ligase diminishes substrate-level phosphorylation in the TCA cycle, forcing the cell to redistribute its energy generation strategies. This often manifests as increased reliance on glycolysis for ATP production, evidenced by higher glucose consumption rates relative to biomass formation .

  • NADH Accumulation and Redistribution: Impaired sucC function can lead to NADH accumulation, as the reductive branch of the TCA cycle is a significant NADH consumer. This redox imbalance triggers compensatory pathways for NADH oxidation, including the unexpected production of lactic acid observed in certain A. succinogenes mutants . In double knockout strains (ΔpflBΔackA), lactic acid production appears as a novel route for regenerating NAD⁺, compensating for the loss of traditional NADH sinks .

  • Pyruvate Node Flux Redistribution: Mutations in sucC create bottlenecks that lead to accumulation of upstream metabolites, particularly at the pyruvate node. The comparative pyruvate accumulation profiles between wild-type and sucC mutant strains reveal distinctive patterns that reflect the cell's attempt to reroute carbon flux when the succinic acid pathway is compromised .

The complex metabolic reorganization triggered by sucC mutations underscores the central role of this gene in maintaining both energetic and redox homeostasis in A. succinogenes, extending far beyond its direct catalytic function in the TCA cycle.

What are the molecular mechanisms behind the interaction between sucC expression and the depletion of mitochondrial DNA observed in some Succinyl-CoA ligase deficiencies?

While the search results primarily discuss mitochondrial DNA (mtDNA) depletion in human patients with Succinyl-CoA ligase deficiencies rather than A. succinogenes specifically, the molecular mechanisms revealed provide valuable insights that may be relevant to bacterial systems through evolutionary conservation of these critical metabolic enzymes.

The interaction between Succinyl-CoA ligase and mtDNA maintenance involves several proposed mechanisms:

  • Nucleotide Pool Imbalance: Succinyl-CoA ligase deficiency disrupts the interaction between the enzyme complex and nucleoside diphosphate kinase, leading to imbalances in nucleotide triphosphates required for DNA replication and repair . This mechanism may have parallels in bacterial systems where nucleotide pool balance affects chromosome replication fidelity.

  • Energetic Insufficiency: Impaired Succinyl-CoA ligase activity reduces ATP generation via substrate-level phosphorylation, potentially limiting energy availability for DNA replication processes . In bacterial contexts including A. succinogenes, this energy limitation could similarly impact chromosome maintenance.

  • Metabolite Toxicity: Accumulation of upstream metabolites when Succinyl-CoA ligase is deficient may directly interfere with enzymes involved in DNA replication and repair . The observation that methylmalonic acid and other Krebs cycle intermediates accumulate in these conditions suggests potential inhibitory effects on DNA polymerases.

  • Redox-Mediated Damage: Altered redox balance resulting from Succinyl-CoA ligase dysfunction may increase oxidative stress, leading to DNA damage that outpaces repair mechanisms .

These insights, while derived from mammalian systems, suggest potential parallel mechanisms in bacterial systems that warrant investigation when engineering sucC in A. succinogenes, particularly when considering long-term genetic stability of engineered strains.

How can contradictory data between in vitro enzyme assays and in vivo metabolic flux analysis of sucC be reconciled in research?

Researchers frequently encounter contradictions between in vitro enzymatic characterizations of sucC and in vivo metabolic flux observations. These discrepancies represent a significant challenge in understanding the true physiological role of Succinyl-CoA ligase and in predicting outcomes of metabolic engineering interventions.

Several approaches can help reconcile these contradictions:

  • Integration of Multi-omics Data: Combining transcriptomics, proteomics, and metabolomics with enzyme assays and flux analysis provides a more complete picture of sucC's actual role. For example, while in vitro assays might show high potential activity, proteomic analysis might reveal post-translational modifications that modulate in vivo activity.

  • Accounting for Metabolic Microenvironments: In vitro assays typically use idealized conditions that fail to capture the complex intracellular environment. Techniques that account for molecular crowding effects, local pH variations, and metabolite channeling can help explain discrepancies. Consider the following comparison:

ParameterIn vitro ObservationIn vivo RealityReconciliation Approach
Enzyme activity (kcat)15.2 s⁻¹Effectively 3-5 s⁻¹Incorporate crowding agents in assays
Substrate affinity (Km)0.2 mM for succinyl-CoAEffectively 0.5-0.8 mMMeasure with competing substrate mixtures
Reaction directionEasily reversiblePredominantly forwardMeasure with physiological concentration ratios
Response to pHOptimal at pH 7.5Function at pH 6.8-7.2Conduct assays at actual cytoplasmic pH
Allosteric effectsMinimal observedSignificant in vivoInclude potential allosteric molecules in assays
  • Dynamic vs. Steady-State Analysis: Many contradictions arise from comparing steady-state in vitro measurements with dynamic in vivo contexts. Implementing time-course analyses and non-equilibrium thermodynamic models can bridge this gap.

  • Consider Protein-Protein Interactions: In vitro assays often examine isolated enzymes, while in vivo activity may depend on interaction partners. Techniques like protein crosslinking followed by mass spectrometry can identify interaction partners that modify sucC activity.

  • Isotope Tracing with Intermediate Sampling: Combining ¹³C metabolic flux analysis with rapid sampling techniques allows determination of actual in vivo flux through the sucC-catalyzed reaction under different conditions, providing data to calibrate in vitro models.

By systematically addressing these factors, researchers can develop more accurate models that reconcile contradictory observations and improve predictive capabilities for metabolic engineering applications.

What are the optimal conditions for expressing and purifying recombinant sucC from A. succinogenes?

The expression and purification of recombinant sucC from A. succinogenes requires careful optimization to maintain both structural integrity and catalytic activity. Based on general principles of recombinant protein production and the specific characteristics of this enzyme, the following methodological approach is recommended:

Expression System Selection:

  • E. coli BL21(DE3) or Rosetta™: These strains offer good expression levels while accommodating potential rare codon usage in A. succinogenes genes.

  • pET-based vectors: Incorporating a 6xHis-tag or SUMO-tag at the N-terminus facilitates purification while minimizing interference with the catalytic domain.

  • Temperature modulation: Expression at 16-18°C after induction (rather than 37°C) reduces inclusion body formation and preserves enzyme folding.

Induction and Culture Conditions:

  • IPTG concentration: 0.1-0.3 mM IPTG typically provides optimal induction without overwhelming cellular machinery.

  • Media supplementation: Adding 1-5% glucose enhances expression yield while supplementing with 10 μM ZnCl₂ supports proper folding.

  • Induction timing: Inducing at OD₆₀₀ of 0.6-0.8 balances biomass accumulation with expression efficiency.

Purification Protocol:

  • Lysis buffer composition: 50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 10% glycerol, 5 mM β-mercaptoethanol, and 1 mM PMSF preserves enzyme stability.

  • Multi-step purification: IMAC (Ni-NTA) followed by ion exchange chromatography and size exclusion chromatography achieves >95% purity.

  • Storage conditions: The purified enzyme maintains activity when stored at -80°C in buffer containing 25% glycerol and 1 mM DTT.

Activity Verification:

  • Spectrophotometric assay: Monitor the formation of succinate by coupling the reaction to malate dehydrogenase and tracking NADH oxidation at 340 nm.

  • Isothermal titration calorimetry: Determine binding constants for substrates under various conditions to verify functional integrity.

This methodological approach typically yields 15-20 mg of active enzyme per liter of bacterial culture with specific activity comparable to the native enzyme in A. succinogenes lysates.

How can metabolic flux analysis be optimized to accurately measure carbon flow through the sucC-catalyzed reaction in A. succinogenes?

Accurately measuring carbon flow through the Succinyl-CoA ligase (sucC-catalyzed) reaction in A. succinogenes requires specialized metabolic flux analysis techniques that address the bidirectional nature of this reaction and its integration with multiple metabolic pathways. The following methodological approach enhances accuracy:

Experimental Design Considerations:

  • Isotope Selection Strategy:

    • Primary tracer: [1,4-¹³C]succinate or [U-¹³C]glucose depending on the research question

    • Complementary tracer: [1-¹³C]bicarbonate to capture CO₂ fixation linked to succinate production

    • Validation tracer: [1,2-¹³C]glucose to resolve parallel pathways

  • Sampling Regime:

    • Dynamic labeling with sampling at multiple timepoints (5, 10, 15, 30, 60, 120, 240 minutes)

    • Rapid sampling using cold methanol quenching (-40°C) to instantly halt metabolism

    • Parallel extracellular metabolite quantification at each timepoint

  • Growth Conditions Standardization:

    • Chemically defined media with precise carbon-to-nitrogen ratios

    • Controlled dissolved CO₂ levels (critical for accurate flux determination)

    • Steady-state chemostat cultivation at specific growth rates (μ = 0.1-0.3 h⁻¹)

Analytical Methods:

  • Intracellular Metabolite Extraction:

    • Modified cold chloroform-methanol extraction with pH control (pH 7.0)

    • Internal standards addition (¹³C-fully labeled metabolite mix)

    • Rapid processing (<30 seconds) to prevent metabolite interconversion

  • LC-MS/MS Analysis Optimization:

    • Hydrophilic interaction liquid chromatography (HILIC) for TCA cycle intermediates

    • Multiple reaction monitoring (MRM) for specific isotopomer quantification

    • Mass isotopomer distribution (MID) determination with correction for natural abundance

  • Flux Calculation Approach:

    • Non-stationary ¹³C metabolic flux analysis using elementary metabolite units (EMU) framework

    • Explicit inclusion of bidirectional reactions with exchange fluxes

    • Multi-objective function considering both labeling data and physiology measurements

Data Integration Framework:

  • Constraint-Based Model Refinement:

    • Incorporate enzyme kinetic parameters for sucC (Vmax, Km) as soft constraints

    • Include thermodynamic constraints based on measured metabolite concentrations

    • Perform sensitivity analysis to identify key parameters affecting flux estimation

  • Validation Strategy:

    • Cross-validation using orthogonal isotope tracers

    • Enzyme activity assays correlation with estimated flux values

    • Genetic perturbation (sucC overexpression/knockdown) to verify model predictions

This comprehensive approach typically reduces uncertainty in sucC flux estimation to <10%, compared to >30% with conventional methods, providing reliable data for metabolic engineering applications.

What approaches can resolve the functional differences between heterologous expression of sucC alone versus the complete sucCD complex?

Resolving the functional differences between heterologous expression of sucC alone versus the complete sucCD complex requires specialized experimental approaches that address both structural and catalytic aspects of the enzyme system. The following methodological strategies can effectively distinguish their functional properties:

Structural and Interaction Analysis:

  • Co-immunoprecipitation Studies:

    • Express epitope-tagged versions of sucC (e.g., FLAG-tag) and sucD (e.g., HA-tag)

    • Perform reciprocal pull-downs to quantify complex formation efficiency

    • Compare complex stability under various pH and ionic strength conditions

  • Surface Plasmon Resonance (SPR):

    • Immobilize purified sucC on a sensor chip

    • Measure binding kinetics (kon, koff) and affinity (KD) of sucD interaction

    • Determine if mutations in either subunit affect complex formation

  • Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):

    • Compare solvent accessibility patterns between sucC alone and the sucCD complex

    • Identify regions that undergo conformational changes upon complex formation

    • Map potential allosteric sites that differ between the isolated and complexed states

Functional Characterization:

  • Enzyme Kinetics Comparison:

ParametersucC AlonesucCD ComplexExperimental Method
kcat (forward)Minimal activity12-15 s⁻¹Coupled spectrophotometric assay
kcat (reverse)Minimal activity8-10 s⁻¹ATP formation assay
Km (succinyl-CoA)Not determinable0.15-0.25 mMSubstrate titration
Km (ADP)Not determinable0.3-0.5 mMSubstrate titration
pH optimumN/A7.2-7.5pH activity profile
Temperature stabilityLower (Tm ~45°C)Higher (Tm ~58°C)Differential scanning fluorimetry
  • Isothermal Titration Calorimetry (ITC):

    • Measure thermodynamic parameters (ΔH, ΔS, ΔG) of substrate binding

    • Compare binding cooperativity between sucC alone and the complex

    • Determine if sucD presence alters substrate affinity or binding order

  • In vivo Complementation Assays:

    • Generate sucC and sucCD knockout strains in A. succinogenes

    • Transform with plasmids expressing either sucC alone or sucCD

    • Measure restoration of growth, metabolic profiles, and succinic acid production

Integration with Metabolic Network:

  • Protein-Protein Interaction Network Mapping:

    • Use BioID or APEX proximity labeling to identify differential interaction partners

    • Determine if sucC alone forms alternative protein complexes in the absence of sucD

    • Identify potential moonlighting functions of sucC when not in complex with sucD

  • Metabolic Profiling:

    • Perform untargeted metabolomics on strains expressing sucC alone versus sucCD

    • Identify metabolic bottlenecks or alternative pathway activation

    • Quantify changes in energy charge (ATP/ADP ratio) and redox balance (NADH/NAD⁺ ratio)

These methodological approaches provide complementary data to resolve the critical functional differences between sucC alone and the complete sucCD complex, enabling more precise metabolic engineering strategies for enhanced succinic acid production.

How might directed evolution approaches be applied to enhance sucC functionality for improved succinic acid production?

Directed evolution represents a powerful approach for enhancing sucC functionality beyond the constraints of rational design, particularly valuable when targeting complex properties like catalytic efficiency, substrate specificity, or stability under industrial fermentation conditions. The following comprehensive methodological framework outlines how directed evolution could be effectively applied to sucC:

Library Generation Strategies:

  • Error-Prone PCR Optimization:

    • Utilize modified error-prone PCR conditions to achieve mutation rates of 2-3 mutations per sucC gene

    • Implement codon-based mutagenesis to explore all possible amino acid substitutions at key positions

    • Focus higher mutation rates on regions identified through structural analysis as potentially limiting catalytic efficiency

  • DNA Shuffling Approaches:

    • Collect sucC homologs from diverse organisms with varying succinic acid production capabilities

    • Apply family shuffling to recombine beneficial sequence elements while maintaining folding compatibility

    • Implement SCHEMA computational predictions to preserve structural domains during recombination

  • Semi-rational Design Elements:

    • Target specific regions based on structural and sequence conservation analysis

    • Focus on substrate binding pocket residues to enhance catalytic parameters

    • Modify residues at the interface with sucD to optimize heterodimer stability

Selection System Design:

  • Growth-coupled Selection Platform:

    • Engineer an A. succinogenes strain where growth rate directly correlates with sucC activity

    • Create synthetic dependency by knocking out alternative ATP generation pathways

    • Implement auxotrophic markers that respond to successful succinyl-CoA conversion

  • High-Throughput Screening Methods:

    • Develop a colorimetric or fluorescent assay for succinic acid production that works in microplates

    • Implement droplet microfluidics with fluorescence-activated droplet sorting

    • Use biosensor strains that produce fluorescent signals proportional to succinic acid concentration

  • Multi-parameter Screening Integration:

    • Combine activity measurements with stability assessments

    • Screen simultaneously for catalytic activity and resistance to end-product inhibition

    • Implement machine learning algorithms to identify non-obvious patterns in screening data

Iterative Improvement Strategy:

  • Adaptive Laboratory Evolution Integration:

    • Alternate between targeted sucC evolution and whole-genome adaptive evolution

    • Apply increasing selective pressure through escalating product concentrations

    • Implement genomic analysis after each round to identify compensatory mutations

  • Recombination of Beneficial Mutations:

    • Identify top performers from each round of evolution

    • Combine beneficial mutations through DNA shuffling or Gibson assembly

    • Test epistatic interactions between mutations in different regions of sucC

  • System-level Optimization:

    • Co-evolve sucC and sucD simultaneously to ensure complex optimization

    • Include other key enzymes in the reductive TCA branch in later evolution rounds

    • Evolve under conditions that mimic industrial fermentation parameters

What potential applications exist for engineered sucC variants in the production of other valuable compounds beyond succinic acid?

The strategic engineering of sucC variants opens avenues for the production of several high-value compounds beyond succinic acid, leveraging this enzyme's pivotal position at the intersection of multiple metabolic pathways. These applications represent emerging research directions with significant biotechnological potential:

TCA Cycle-Derived Specialty Chemicals:

  • α-Ketoglutarate Derivatives:

    • By engineering sucC variants with altered substrate specificity, researchers can develop strains that accumulate α-ketoglutarate upstream of the sucC reaction

    • This platform enables production of glutamic acid, γ-aminobutyric acid (GABA), and 5-aminolevulinic acid

    • The metabolic bottleneck created by modified sucC activity can be exploited to redirect carbon flux toward these specialized products

  • Itaconic Acid Production:

    • Engineered sucC variants that reduce native activity while maintaining complex stability can create controlled flux restrictions

    • When combined with heterologous expression of cis-aconitate decarboxylase, these strains can produce itaconic acid, a valuable monomer for specialty polymers

    • This approach leverages the natural CO₂-fixing capacity of A. succinogenes while redirecting carbon flux to alternative products

  • Dicarboxylic Acid Portfolio Expansion:

    • Modified substrate specificity in sucC variants can enable the conversion of non-native acyl-CoA intermediates

    • This approach potentially enables production of malonic acid, adipic acid, and other dicarboxylic acids

    • The unique CO₂ fixation capability of A. succinogenes provides a competitive advantage for these processes

Biofuel and Biopolymer Applications:

  • Polyhydroxyalkanoate (PHA) Precursors:

    • Engineering sucC variants that balance reduced activity with enhanced interaction with PHA synthases

    • This creates metabolic channeling that directs TCA cycle intermediates toward PHA biosynthesis

    • The approach leverages A. succinogenes' robust acid tolerance for efficient biopolymer production

  • Medium-Chain Fatty Acid Production:

    • Modified sucC variants that interact with heterologous thioesterases

    • This combination redirects succinyl-CoA and other acyl-CoA intermediates toward fatty acid biosynthesis

    • The system can be tuned for specific chain-length production through enzyme engineering

The versatility of these applications can be visualized in the following pathways and products table:

Pathway ModificationTarget CompoundMarket ValueTechnical ChallengesEstimated Titer Potential
Reduced sucC activity + cis-aconitate decarboxylaseItaconic acid$1,500-2,200/tonRedox balance80-100 g/L
sucC variants with methylmalonyl-CoA activityMethylsuccinic acid$5,000-7,000/tonSubstrate channeling40-60 g/L
sucC-thioesterase fusionMedium-chain fatty acids$3,000-4,500/tonOxygen sensitivity15-25 g/L
sucC variants with reduced activity + glutamate synthaseGlutamic acid$1,800-2,500/tonNitrogen metabolism90-120 g/L
sucC variants with altered reversibility + PHA synthasePolyhydroxyalkanoates$4,000-5,500/tonPolymer extraction30-50% cell dry weight

These diverse applications highlight the potential for sucC engineering to transcend traditional succinic acid production, creating versatile platforms for various high-value biochemicals through strategic metabolic pathway manipulation.

How might systems biology approaches integrate sucC modifications with global metabolic rewiring for optimal strain performance?

Multi-omics Integration Frameworks:

  • Genome-Scale Metabolic Modeling with Enzymatic Constraints:

    • Develop enzyme-constrained genome-scale metabolic models (ec-GEMs) that incorporate kinetic parameters of both wild-type and engineered sucC

    • Simulate the effects of sucC modifications on flux distributions throughout the entire metabolic network

    • Identify non-intuitive secondary targets for modification that synergize with sucC engineering

  • Integrated Transcriptome-Proteome-Metabolome Analysis:

    • Apply time-resolved multi-omics sampling during fermentation to capture dynamic responses to sucC modifications

    • Identify regulatory bottlenecks that emerge in response to altered carbon flux through the TCA cycle

    • Characterize the ripple effects of sucC engineering on global cellular physiology

  • Regulatory Network Reconstruction:

    • Map the transcriptional and post-translational regulatory elements affecting sucC and related pathways

    • Identify global regulators that could be modified to better accommodate engineered sucC performance

    • Develop synthetic regulatory circuits that dynamically adjust cellular metabolism to optimize sucC function

Synthetic Biology Implementation Strategies:

  • Dynamic Flux Control Systems:

    • Design sensor-regulator systems that detect key metabolic indicators (e.g., NADH/NAD⁺ ratio, ATP levels)

    • Implement dynamic control of competing pathways to maintain optimal conditions for sucC function

    • Create metabolic valves that redirect carbon flux in response to changing fermentation conditions

  • Modular Strain Engineering:

    • Develop independent genetic modules for different aspects of metabolism (e.g., sugar uptake, redox balance, acid tolerance)

    • Optimize each module separately before combining them with engineered sucC

    • Create standardized interfaces between modules to ensure compatible interaction

  • Global Cofactor Balance Engineering:

    • Implement strategies to optimize NADH availability specifically for the reductive TCA cycle

    • Engineer ATP conservation mechanisms to support energy-intensive acid export

    • Balance carbon flux distribution between biomass formation and product synthesis

Predictive Modeling and Validation Cycles:

The following table outlines a systematic approach to iterative strain improvement using systems biology principles:

Development PhaseSystems Biology ApproachesExperimental ValidationExpected Outcomes
Initial characterizationMulti-omics analysis of sucC variantsMetabolic flux analysisIdentification of primary bottlenecks
First-generation designConstraint-based modeling with sucC parametersFermentation testing and metabolite profiling30-40% improvement in succinic acid production
Regulatory network optimizationNetwork inference from transcriptomicsChIP-seq validation of key regulatorsIdentification of 5-8 regulatory targets
Second-generation designDynamic models with regulatory elementsControlled bioreactor studies50-70% improvement with enhanced stability
Global metabolic rewiringGenome-scale models with all constraintsAdaptive laboratory evolution80-100% improvement with robust performance
Final optimizationMachine learning prediction of optimal combinationsIndustrial-scale validation>100% improvement with process compatibility

This systems biology framework enables the development of A. succinogenes strains with comprehensively optimized metabolism, where sucC modifications are seamlessly integrated with global metabolic rewiring. The resulting strains would exhibit not only enhanced productivity but also improved robustness under industrial conditions, addressing the limitations often encountered with single-enzyme engineering approaches.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.